Global Opioid Dependence Treatment Market DJPR

1. Opioid Dependence Treatment Market 2023-2035 Competitive Landscape Growth at a CAGR of ~9% Global Opioid Dependence Treatment Market Key Insights During the forecast period of 2023-2035, the global opioid dependence treatment market is expected to reach an estimated value of ~USD 7 billion by 2035, by expanding at a CAGR of ~9%. The market further generated a revenue of ~USD 3 billion in the year 2022. Major key factors propelling the growth of opioid dependence treatment market worldwide are the growing cases of opioid abuse, and addiction of individuals on illegal opioid drugs all across the globe. Market Definition of Opioid Dependence Treatment Aspects of opioid dependency and opioid use disorders are combined in opioid dependence. Many different locations and pharmacological and behavioral treatment modalities are employed to treat opioid drug addiction. Most currently being utilized treatments focus on maintenance therapy using buprenorphine, an opioid agonist, together with methadone, naltrexone, or an opioid antagonist. As a rescue medication in the case of an overdose, buprenorphine is occasionally used with naloxone in rare circumstances. Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4003 Global Opioid Dependence Treatment Market: Growth Drivers The growth of the global opioid dependence treatment market can majorly be attributed to the growing consumption of opioid drugs, which could further cause opioid use disorder among people. Opioid use disorder (OUD) has affected 3 million US residents and 16 million other people worldwide. Further, in the United States, about 500,000 people are addicted to heroin. Opioid addiction is a chronic disease that could have serious negative effects on one's health, relationships, and finances. Opioids are a group of medications that work on the neurological system to relieve pain and elicit a sense of euphoria. Hence, growth in the number of people suffering from chronic illnesses is also expected to consume opioid drugs further boosting the growth of the market. For instance, nearly half of all Americans—roughly 45%, or 133 million people—suffer from at least one chronic illness, and the number is rising. However, despite being

2. often used for therapeutic purposes, opioid medicines carry the risk of abuse, dependency, and other health issues if used excessively or without supervision. For instance, according to the World Health Organization, drug use is responsible for 0.5 million fatalities globally. Overdose is the primary cause of nearly 30% of these deaths, which have an opioid connection in excess of 70%. Hence this factor is expected to boost the growth of the market in coming years. The global opioid dependence treatment market is also estimated to grow majorly on account of the following: •Growing Government Initiatives to Tackle Opioid Dependence Treatment Effectively •Surge in Consideration of Buprenorphine Patches •Increasing Engagement of Non-Government Organization Request for customization @https://www.researchnester.com/customized-reports-4003 Global Opioid Dependence Treatment Market: Restraining Factor The side effects that could result from the medications used to treat opioid addiction are one of the most important restraints that are projected to restrict the expansion of the global market over the forecast period. Vomiting, bladder pain, abdominal cramps, diarrhoea, respiratory problems, bone/joint pain, muscular aches, and constipation are just a few of the common side effects from these medications. Additionally, in very severe circumstances of adverse effects, the patient may also experience psychological issues including depression. In some instances, using SUBOXONE to treat opioid dependence might cause hyperventilation and a fast or irregular heartbeat. Thus, it is anticipated that during the projection period, these medications' negative effects would impede market expansion. Global Opioid Dependence Treatment Market Segmentation •By Drug Class (Naloxone, Buprenorphine, and Methadone) The buprenorphine segment is anticipated to hold the largest market share over the forecast period. The growth of this segment could be attributed to the growing usage of buprenorphine for opioid use disorder. Buprenorphine is a medicine licensed by the Food and Drug

3. Administration (FDA) as a medication-assisted treatment (MAT) for Opioid Use Disorder (OUD). However, overdose of buprenorphine could cause adverse effect on health. In the past few years, it has been observed that the misuse of buprenorphine was on the rise, mostly among heroin users. The high opioid abuse in order to treat pain, manage psychiatric disorders, get high, manage withdrawal symptoms, and more, further lead to high consumption of buprenorphine as to wean themselves off opioids. However, prevalence of Buprenorphine abuse among adults with OUD decreased from 2015 to 2019. In 2019, approximately 2.4 million US individuals used buprenorphine, and close to 0.7 million abused it, compared to approximately 4.9 million and about 3.0 million in previous years, respectively, who misused hydrocodone and oxycodone. •By Sales Channel (Retail Pharmacies, Online Pharmacies, Hospitals, and Rehabilitation Centers) •By Region The North America opioid dependence treatment market is anticipated to hold the largest market share by the end of 2035 among the market in all the other regions, backed by rising awareness among general population about opioid use disorder, and growth in patient pool in the region. According to a survey conducted in 2019 by the U.S. Department of Health and Human Services, 10.1 million adults aged 12 and older abused opioids in 2018, compared to 9.7 million adults who misused prescription painkillers. The market research report on global opioid dependence treatment also includes the market size, market revenue, Y-o-Y growth, and key player analysis applicable for the market in North America (U.S., and Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia- Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), and Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa). Key Market Players Featured in the Global Opioid Dependence Treatment Market

4. Some of the key players of the global opioid dependence treatment market are Orexo AB, Indivior PLC, Titan Pharmaceuticals, Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, BioDelivery Sciences International Inc., Teva Pharmaceutical Industries Ltd., Alkermes, Camurus AB, and others. Obtain this Report @https://www.researchnester.com/reports/opioid-dependence- treatment-market/4003 About Research Nester Research Nester, which is a leading service provider for strategic market research and consulting services, aims to provide unbiased, unparalleled market insights and industry analysis. These analyses help conglomerates, executives, and industries to take wise decisions for their businesses as well as for their future marketing strategy, expansion and investment among others. We believe that our expertise in the field of market research can help businesses to expand to its new horizon. Our team of research analysts can provide businesses a right guidance at the right time, while our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919